Prokidney (PROK) Consolidated Net Income (2021 - 2026)

Prokidney (PROK) reported Consolidated Net Income of -$42.6 million for Q1 2026, down 12.3% year-over-year from -$48.6 million in Q1 2025, and down 4.33% on a QoQ basis from -$40.9 million in Q4 2025.

Prokidney (PROK) has 6 years of Consolidated Net Income data on file, last reported at -$42.6 million in Q1 2026.

  • Quarterly Consolidated Net Income fell 12.3% year-over-year to -$42.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$156.3 million (up 5.83% YoY) and the FY2025 annual result came in at -$151.6 million, up 7.18% from the prior year.
  • Consolidated Net Income retreated to -$42.6 million in Q1 2026 per PROK's latest filing, from -$40.9 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$21.7 million in Q4 2023 and bottomed at -$67.5 million in Q1 2022.
  • The 5-year median for Consolidated Net Income is -$37.0 million (2025), against an average of -$37.7 million.
  • The widest annual swing landed in 2022, when Consolidated Net Income sank 1302215.71%; it then jumped 45.31% in 2023.
  • Tracing PROK's Consolidated Net Income over 5 years: stood at -$24.6 million in 2022, then increased by 11.59% to -$21.7 million in 2023, then tumbled by 123.18% to -$48.5 million in 2024, then grew by 15.74% to -$40.9 million in 2025, then slipped by 4.33% to -$42.6 million in 2026.
  • Per Business Quant, the three latest PROK Consolidated Net Income figures stand at -$42.6 million (Q1 2026), -$40.9 million (Q4 2025), and -$35.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.99 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -8.40 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -3.40 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 205.99 Mn
10 Prokidney 259.72 Mn 1.55 Bn - -42.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -42.62 Mn
Dec 31, 2025 -40.85 Mn
Sep 30, 2025 -35.84 Mn
Jun 30, 2025 -36.97 Mn
Mar 31, 2025 -37.95 Mn
Dec 31, 2024 -48.48 Mn
Sep 30, 2024 -41.05 Mn
Jun 30, 2024 -38.47 Mn
Mar 31, 2024 -35.33 Mn
Dec 31, 2023 -21.72 Mn
Sep 30, 2023 -41.99 Mn
Jun 30, 2023 -34.82 Mn
Mar 31, 2023 -36.91 Mn
Dec 31, 2022 -24.57 Mn
Sep 30, 2022 -33.95 Mn
Jun 30, 2022 -22.13 Mn
Mar 31, 2022 -67.49 Mn
Dec 31, 2021 -13.82 Mn
Sep 30, 2021 -17.02 Mn
Jun 30, 2021 -5,325.00
Mar 31, 2021 -5,182.00